Source link : https://todaynewsgazette.com/2026/07/10/science/article31868/
In the early 1960s, thalidomide emerged as a widely hailed treatment for morning sickness and insomnia, rapidly gaining acceptance across numerous countries. Yet beneath its promising facade lay a grave hazard that soon manifested in thousands of children born with severe birth defects worldwide. While many nations grappled with this pharmaceutical disaster, the United States narrowly escaped widespread tragedy due to the unwavering resolve of one remarkable individual. This article explores her crucial role in safeguarding American public health and transforming drug safety regulations permanently. Her story highlights the indispensable need for stringent oversight within the pharmaceutical sector and demonstrates how one person’s commitment can avert catastrophe on an immense scale.
Frances Kelsey: The Tenacious Defender Who Halted Thalidomide’s Approval
At a time when thalidomide was embraced throughout Europe as a safe remedy for pregnancy-related nausea, Frances Kelsey stood resolute at the U.S. Food and Drug Administration (FDA), refusing to authorize its use without extensive scrutiny. As a dedicated medical officer focused on patient protection, Kelsey carefully reviewed all available evidence and uncovered notable deficiencies concerning thalidomide’s impact on fetal progress.
Her insistence on demanding rigorous safety data delayed approval long enough to prevent mass distribution in America—ultimately sparing countless families from devastating…
—-
Author : TodayNewsGazette
Publish date : 2026-07-10 15:21:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8